Congressional Briefing: Stopping HPV-Associated Cancers Via Vaccination and Screening

Cancers attributable to human papillomavirus (HPV), which embrace cervical, throat, head, neck, anal, penile and vaginal, stay a big public well being drawback in america. Cervical most cancers is the fourth most typical most cancers in ladies worldwide and an estimated 4,300 deaths from cervical most cancers will happen in 2023 within the U.S.

Fortuitously, along with important screening and early remedy, there may be an HPV vaccine that protects towards the forms of HPV that trigger most cervical and different HPV-associated cancers. This vaccine is a serious development because it affords major prevention towards the infectious agent that’s the major explanation for HPV-related cancers. Information demonstrates that HPV vaccination might forestall greater than 90% of HPV-caused cancers.

Regardless of the demonstrated success of screening and the HPV vaccine, vaccination and screening charges nonetheless fall under nationwide targets, and solely worsened through the pandemic.

Be part of our Congressional Briefing: Stopping HPV-Associated Cancers Via Vaccination and Screening to learn the way the HPV vaccine, screening and early remedy are highly effective instruments to assist finish a number of cancers and what actions Congress can take to assist obtain elevated uptake of those modalities all through the nation.

Register In the present day